254 related articles for article (PubMed ID: 33602926)
1. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.
Wipperman MF; Bhattarai SK; Vorkas CK; Maringati VS; Taur Y; Mathurin L; McAulay K; Vilbrun SC; Francois D; Bean J; Walsh KF; Nathan C; Fitzgerald DW; Glickman MS; Bucci V
Nat Commun; 2021 Feb; 12(1):1141. PubMed ID: 33602926
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
[TBL] [Abstract][Full Text] [Related]
3. Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota.
Namasivayam S; Diarra B; Diabate S; Sarro YDS; Kone A; Kone B; Tolofoudie M; Baya B; Diakite MT; Kodio O; Cohen K; Holl J; Achenbach CJ; Chatterjee S; Murphy RL; Bishai W; Diallo S; Sher A; Maiga M
PLoS Negl Trop Dis; 2020 May; 14(5):e0008230. PubMed ID: 32401750
[TBL] [Abstract][Full Text] [Related]
4. The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
Namasivayam S; Sher A; Glickman MS; Wipperman MF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228238
[TBL] [Abstract][Full Text] [Related]
5. The host microbiome and impact of tuberculosis chemotherapy.
O'Toole RF; Gautam SS
Tuberculosis (Edinb); 2018 Dec; 113():26-29. PubMed ID: 30514510
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Eribo OA; du Plessis N; Ozturk M; Guler R; Walzl G; Chegou NN
Cell Mol Life Sci; 2020 Apr; 77(8):1497-1509. PubMed ID: 31729564
[TBL] [Abstract][Full Text] [Related]
7. Microbiome-immune interactions in tuberculosis.
Mori G; Morrison M; Blumenthal A
PLoS Pathog; 2021 Apr; 17(4):e1009377. PubMed ID: 33857251
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
[TBL] [Abstract][Full Text] [Related]
9. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances.
Osei Sekyere J; Maningi NE; Fourie PB
Ann N Y Acad Sci; 2020 May; 1467(1):21-47. PubMed ID: 31989644
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of serum bradykinin and desArg
Qian X; Nguyen DTM; Li Y; Lyu J; Graviss EA; Hu TY
Tuberculosis (Edinb); 2016 Dec; 101S():S109-S118. PubMed ID: 27720377
[TBL] [Abstract][Full Text] [Related]
13. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans.
Huang SF; Yang YY; Chou KT; Fung CP; Wang FD; Su WJ
Eur J Clin Invest; 2019 May; 49(5):e13068. PubMed ID: 30620398
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
[TBL] [Abstract][Full Text] [Related]
15. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
[TBL] [Abstract][Full Text] [Related]
16. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease.
Gordhan BG; Peters J; Kana BD
Adv Appl Microbiol; 2019; 108():115-161. PubMed ID: 31495404
[TBL] [Abstract][Full Text] [Related]
17. Microbiome Changes during Tuberculosis and Antituberculous Therapy.
Hong BY; Maulén NP; Adami AJ; Granados H; Balcells ME; Cervantes J
Clin Microbiol Rev; 2016 Oct; 29(4):915-26. PubMed ID: 27608937
[TBL] [Abstract][Full Text] [Related]
18. Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.
Tientcheu LD; Maertzdorf J; Weiner J; Adetifa IM; Mollenkopf HJ; Sutherland JS; Donkor S; Kampmann B; Kaufmann SH; Dockrell HM; Ota MO
Genes Immun; 2015; 16(5):347-55. PubMed ID: 26043170
[TBL] [Abstract][Full Text] [Related]
19. Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.
Mesquita ED; Gil-Santana L; Ramalho D; Tonomura E; Silva EC; Oliveira MM; Andrade BB; Kritski A;
BMC Infect Dis; 2016 Aug; 16():368. PubMed ID: 27494953
[TBL] [Abstract][Full Text] [Related]
20. Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption.
Bhattarai SK; Du M; Zeamer AL; M Morzfeld B; Kellogg TD; Firat K; Benjamin A; Bean JM; Zimmerman M; Mardi G; Vilbrun SC; Walsh KF; Fitzgerald DW; Glickman MS; Bucci V
Sci Transl Med; 2024 Jan; 16(730):eadi9711. PubMed ID: 38232140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
